<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01936350</url>
  </required_header>
  <id_info>
    <org_study_id>05378712.0.0000.0045</org_study_id>
    <nct_id>NCT01936350</nct_id>
  </id_info>
  <brief_title>Sildenafil Impact on Ventricular Function in Patients With Heart Failure</brief_title>
  <official_title>Sildenafil Impact on Ventricular Function in Patients With Heart Failure: Randomized Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Ana Nery</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital Ana Nery</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Twenty-four patients with known heart failure will be recruited. They will undergo a cardiac
      magnetic resonance for ventricular analyses and after this first exam they will be randomized
      to placebo or Sildenafil. After one hour drug intake they will undergo another cardiac
      magnetic resonance to evaluate the drug impact on right and left ventricular function.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Twenty-four patients with known heart failure will be recruited. They will undergo a cardiac
      magnetic resonance for ventricular analyses and after this first exam they will be randomized
      to placebo or sildenafil. After one hour drug intake they will undergo another cardiac
      magnetic resonance to evaluate the drug impact on right and left ventricular function.

      The first and second exams will be performed by the same staff. All patients will be
      evaluated by two, three and four chambers view. Left and right ventricle quantification
      analyses will be performed by Argus software.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2013</start_date>
  <completion_date type="Actual">November 2013</completion_date>
  <primary_completion_date type="Actual">November 2013</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Improvement on ventricular function</measure>
    <time_frame>one hour</time_frame>
    <description>Patients will undergo a cardiac magnetic resonance to evaluate ventricular function after one hour of sildenafil or placebo use</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">24</enrollment>
  <condition>Heart Failure</condition>
  <arm_group>
    <arm_group_label>Sildenafil</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>12 patients will be in this group. They will take a sildenafil 50mg.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>12 patients will be in this group, they will take placebo</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sildenafil</intervention_name>
    <description>The intervention in this group is the use of sildenafil 50mg; this group will take placebo and will be evaluated by cardiac magnetic resonance before and after the oral use of the drug.</description>
    <arm_group_label>Sildenafil</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>This group will use placebo; this group will take placebo and will be evaluated by cardiac magnetic resonance before and after the oral use of the placebo pill.</description>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>Placebo group</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria: Patients with heart failure in stable clinical condition compatible
        with New York Heart Association functional class I to III. Eligibility criteria is consent
        to participate in the study after receiving detailed information about procedures, possible
        clinical benefits, and risks.

        Exclusion Criteria: patients with new diagnosed lesions during the procedure, eg pulmonary
        mass and important claustrophobia, low blood pressure ( systolic blood pressure &lt;90 mmHg or
        diastolic blood pressure &lt;60 mmHg) nitrate or nebivolol use over the last 48 hours,
        metallic non MRI compatible implantable devices.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andre M Fernandes, Master</last_name>
    <role>Study Director</role>
    <affiliation>Hospital Ana Nery - Federal University of Bahia</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital Ana Neri - MRI unit</name>
      <address>
        <city>Salvador</city>
        <state>Bahia</state>
        <zip>40000</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <link>
    <url>http://aplicacao.saude.gov.br/plataformabrasil/visao/pesquisador/gerirPesquisa/gerirPesquisa.jsf</url>
    <description>approved by local Institutional Review Board</description>
  </link>
  <verification_date>November 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 2, 2013</study_first_submitted>
  <study_first_submitted_qc>September 2, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 6, 2013</study_first_posted>
  <last_update_submitted>November 6, 2013</last_update_submitted>
  <last_update_submitted_qc>November 6, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 7, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital Ana Nery</investigator_affiliation>
    <investigator_full_name>Andre Duraes, PhD</investigator_full_name>
    <investigator_title>Doctor</investigator_title>
  </responsible_party>
  <keyword>Heart failure</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sildenafil Citrate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

